While research has uncovered ever more information about the safety and efficacy of various therapies targeting SARS-CoV-2, the virus behind COVID-19, little is known about…
INSERM, a successor to the French National Institute of Health, recently had results from the Phase 3 DisCoVeRy clinical trial published in The Lancet, Infectious…
While the World Health Organization (WHO) Solidarity trial concluded that Gilead’s Remdesivir was not effective in treating COVID-19, that didn’t stop the use in the…
University of Iowa Carver College of Medicine led a multi-site study finding that the only formally approved drug by the U.S. Food and Drug Administration…
What were once hot health care commodities during the pandemic are now laggards as both Remdesivir (Gilead) and Tocilizumab (Roche) barely see shelf movement despite…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
